Additionally, other studies reported even wider prospective applications for GSK-J4, such as in attenuating brainstem glioma or T-cell acute lymphoblastic leukemia (T-ALL), suggesting that GSK-J4 may have anti-inflammatory as well as anti-cancer activities12. Here, IGKJ4 is linked to cancer.